Steven J Demarco

USPTO Granted Patents = 19 (Patent Applications = 1)

CIPO Patents = 11

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 8.9

ph-index = 6

Forward Citations = 93(Granted Patents)

Location History:

Dietgen, CH (2014 - 2020)
Freienstein, CH (2018 - 2020)
Diegten, CH (2010 - 2022)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2010-2022

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11421001 - Template-fixed peptidomimetics (2022-08-23),

2. 10787486 - Template-fixed peptidomimetics (2020-09-29),

3. 10730912 - Template-fixed peptidomimetics with antimicrobial activity (2020-08-04),

4. 10562933 - Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity (2020-02-18),

5. 10144765 - Template-fixed peptidomimetics (2018-12-04),

6. 10100084 - Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity (2018-10-16),

7. 9879047 - Template-fixed peptidomimetics (2018-01-30),

8. 9596852 - Template-fixed peptidomimetics with antimicrobial activity (2017-03-21),

9. 9556234 - Template-fixed peptidomimetics (2017-01-31),

10. 9538752 - Template-fixed peptidomimetics with antimicrobial activity (2017-01-10),

11. 9521846 - Template-fixed peptidomimetics with antimicrobial activity (2016-12-20),

12. 9518092 - Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity (2016-12-13),

13. 8921325 - Template-fixed peptidomimetics (2014-12-30),

14. 8895695 - Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity (2014-11-25),

15. 8685922 - Template-fixed peptidomimetics with antimicrobial activity (2014-04-01),

Title: **Steven J Demarco: Innovator in Peptidomimetics**

Introduction

Steven J Demarco is a prominent inventor based in Diegten, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on peptidomimetics. With a notable portfolio of 19 patents, Demarco's inventions have the potential to enhance therapeutic strategies, especially in cancer treatment.

Latest Patents

Among his latest innovations, Steven has developed template-fixed β-hairpin peptidomimetics that feature a Cyclo(-Tyr-His-X-Cys-Ser-Ala-Pro-Dab-Arg-Tyr-Cys-Tyr-Gln-Lys-Pro-Pro) structure. These compounds, characterized by the disulfide bond between Cys4 and Cys11, exhibit CXCR4 antagonizing properties. Crucially, they can be utilized in contexts where cancer is mediated or exacerbated by CXCR4 receptor activity. This dual-use application showcases the importance of his research in developing targeted cancer therapies.

Career Highlights

Throughout his career, Steven has worked at notable institutions, including Polyphor Ltd. and Universität Zürich. His experiences in these organizations have allowed him to drive forward his research, bringing practical applications to his theoretical findings. Steven's extensive experience in the pharmaceutical field supports his innovative endeavors in drug development.

Collaborations

Collaboration has played a key role in Steven’s success. He has worked alongside esteemed colleagues, such as Frank Gombert and Daniel Obrecht. These partnerships have facilitated the exchange of ideas and knowledge, contributing to the advancement of their collective research efforts in medicinal chemistry.

Conclusion

Steven J Demarco stands out as an influential figure in the realm of peptidomimetics, with a clear focus on combating cancer via innovative drug design. His extensive patent portfolio and collaborations underline his dedication to advancing science and contributing to meaningful medical solutions. Through his groundbreaking work, Demarco continues to pave the way for future innovations in pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.